This is a summary. To read the whole story subscribe to BostonGlobe.com
Hologic Inc. sank after the Bedford company’s 2014 forecasts for sales and adjusted revenues fell short of analysts’ estimates and the company said it expects “headwinds.” At least three firms cut Hologic’s stock to the equivalent of a “hold” rating. Hologic also reported a $1.11 billion write-down. The stock has been volatile in 2013 on doubts about management’s direction, The Motley Fool says. Management now sees 2014 adjusted earnings per share of $1.32 to 1.38, below Wall Street’s view of $1.64.